BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: LeCluyse EL. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci. 2001;13:343-368. [PMID: 11408150 DOI: 10.1016/s0928-0987(01)00135-x] [Cited by in Crossref: 347] [Cited by in F6Publishing: 89] [Article Influence: 17.4] [Reference Citation Analysis]
Number Citing Articles
1 Ning B, Dial S, Sun Y, Wang J, Yang J, Guo L. Systematic and simultaneous gene profiling of 84 drug-metabolizing genes in primary human hepatocytes. J Biomol Screen 2008;13:194-201. [PMID: 18270363 DOI: 10.1177/1087057108315513] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
2 Vliegenthart AD, Tucker CS, Del Pozo J, Dear JW. Zebrafish as model organisms for studying drug-induced liver injury. Br J Clin Pharmacol. 2014;78:1217-1227. [PMID: 24773296 DOI: 10.1111/bcp.12408] [Cited by in Crossref: 90] [Cited by in F6Publishing: 86] [Article Influence: 15.0] [Reference Citation Analysis]
3 Xu H, Zhang Y, Wang P, Zhang J, Chen H, Zhang L, Du X, Zhao C, Wu D, Liu F, Yang H, Liu C. A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine. Acta Pharm Sin B 2021;11:1379-99. [PMID: 34221858 DOI: 10.1016/j.apsb.2021.03.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Borse SP, Singh DP, Nivsarkar M. Understanding the relevance of herb-drug interaction studies with special focus on interplays: a prerequisite for integrative medicine. Porto Biomed J 2019;4:e15. [PMID: 31595257 DOI: 10.1016/j.pbj.0000000000000015] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
5 Mateus A, Treyer A, Wegler C, Karlgren M, Matsson P, Artursson P. Intracellular drug bioavailability: a new predictor of system dependent drug disposition. Sci Rep 2017;7:43047. [PMID: 28225057 DOI: 10.1038/srep43047] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
6 Chai SC, Lin W, Li Y, Chen T. Drug discovery technologies to identify and characterize modulators of the pregnane X receptor and the constitutive androstane receptor. Drug Discov Today 2019;24:906-15. [PMID: 30731240 DOI: 10.1016/j.drudis.2019.01.021] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
7 Croce S, Peloso A, Zoro T, Avanzini MA, Cobianchi L. A Hepatic Scaffold from Decellularized Liver Tissue: Food for Thought. Biomolecules 2019;9:E813. [PMID: 31810291 DOI: 10.3390/biom9120813] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 9.5] [Reference Citation Analysis]
8 Wang H, Tompkins LM. CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. Curr Drug Metab. 2008;9:598-610. [PMID: 18781911 DOI: 10.2174/138920008785821710] [Cited by in Crossref: 219] [Cited by in F6Publishing: 207] [Article Influence: 16.8] [Reference Citation Analysis]
9 Hart SN, Li Y, Nakamoto K, Subileau EA, Steen D, Zhong XB. A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues. Drug Metab Dispos 2010;38:988-94. [PMID: 20228232 DOI: 10.1124/dmd.109.031831] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 16.0] [Reference Citation Analysis]
10 Andria B, Bracco A, Cirino G, Chamuleau RA. Liver Cell Culture Devices. Cell Med 2010;1:55-70. [PMID: 26998397 DOI: 10.3727/215517910X519274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
11 Lin C, Khetani SR. Micropatterned Co-Cultures of Human Hepatocytes and Stromal Cells for the Assessment of Drug Clearance and Drug-Drug Interactions. Curr Protoc Toxicol 2017;72:14.17.1-14.17.23. [PMID: 28463419 DOI: 10.1002/cptx.23] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
12 Norona LM, Fullerton A, Lawson C, Leung L, Brumm J, Kiyota T, Maher J, Khojasteh C, Proctor WR. In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk. Arch Toxicol 2020;94:3185-200. [PMID: 32583097 DOI: 10.1007/s00204-020-02804-4] [Reference Citation Analysis]
13 Huang SB, Chou D, Chang YH, Li KC, Chiu TK, Ventikos Y, Wu MH. Development of a pneumatically driven active cover lid for multi-well microplates for use in perfusion three-dimensional cell culture. Sci Rep 2015;5:18352. [PMID: 26669749 DOI: 10.1038/srep18352] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
14 Zhou D, Sunzel M, Ribadeneira MD, Smith MA, Desai D, Lin J, Grimm SW. A clinical study to assess CYP1A2 and CYP3A4 induction by AZD7325, a selective GABA(A) receptor modulator - an in vitro and in vivo comparison. Br J Clin Pharmacol 2012;74:98-108. [PMID: 22122233 DOI: 10.1111/j.1365-2125.2011.04155.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
15 Li CY, Stevens KR, Schwartz RE, Alejandro BS, Huang JH, Bhatia SN. Micropatterned cell-cell interactions enable functional encapsulation of primary hepatocytes in hydrogel microtissues. Tissue Eng Part A 2014;20:2200-12. [PMID: 24498910 DOI: 10.1089/ten.tea.2013.0667] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 12.0] [Reference Citation Analysis]
16 Maes M, Yanguas SC, Willebrords J, Vinken M. Models and methods for in vitro testing of hepatic gap junctional communication. Toxicol In Vitro 2015;30:569-77. [PMID: 26420514 DOI: 10.1016/j.tiv.2015.09.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
17 Walker PA, Ryder S, Lavado A, Dilworth C, Riley RJ. The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development. Arch Toxicol 2020;94:2559-85. [PMID: 32372214 DOI: 10.1007/s00204-020-02763-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
18 An F, Qu Y, Liu X, Zhong R, Luo Y. Organ-on-a-Chip: New Platform for Biological Analysis. Anal Chem Insights 2015;10:39-45. [PMID: 26640364 DOI: 10.4137/ACI.S28905] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
19 Lynch C, Zhao J, Huang R, Xiao J, Li L, Heyward S, Xia M, Wang H. Quantitative high-throughput identification of drugs as modulators of human constitutive androstane receptor. Sci Rep 2015;5:10405. [PMID: 25993555 DOI: 10.1038/srep10405] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
20 Hernandez JP, Mota LC, Baldwin WS. Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation. Curr Pharmacogenomics Person Med 2009;7:81-105. [PMID: 20871735 DOI: 10.2174/187569209788654005] [Cited by in Crossref: 86] [Cited by in F6Publishing: 80] [Article Influence: 7.2] [Reference Citation Analysis]
21 March S, Ramanan V, Trehan K, Ng S, Galstian A, Gural N, Scull MA, Shlomai A, Mota MM, Fleming HE, Khetani SR, Rice CM, Bhatia SN. Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens. Nat Protoc 2015;10:2027-53. [PMID: 26584444 DOI: 10.1038/nprot.2015.128] [Cited by in Crossref: 83] [Cited by in F6Publishing: 77] [Article Influence: 13.8] [Reference Citation Analysis]
22 Mann A, Pelz T, Rennert K, Mosig A, Decker M, Lupp A. Evaluation of HepaRG cells for the assessment of indirect drug-induced hepatotoxicity using INH as a model substance. Hum Cell 2017;30:267-78. [PMID: 28527127 DOI: 10.1007/s13577-017-0175-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
23 Martinez SM, Bradford BU, Soldatow VY, Kosyk O, Sandot A, Witek R, Kaiser R, Stewart T, Amaral K, Freeman K, Black C, LeCluyse EL, Ferguson SS, Rusyn I. Evaluation of an in vitro toxicogenetic mouse model for hepatotoxicity. Toxicol Appl Pharmacol 2010;249:208-16. [PMID: 20869979 DOI: 10.1016/j.taap.2010.09.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
24 Brown GE, Khetani SR. Microfabrication of liver and heart tissues for drug development. Philos Trans R Soc Lond B Biol Sci 2018;373:20170225. [PMID: 29786560 DOI: 10.1098/rstb.2017.0225] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
25 Choi YY, Seok JI, Kim DS. Flow-Based Three-Dimensional Co-Culture Model for Long-Term Hepatotoxicity Prediction. Micromachines (Basel) 2019;11:E36. [PMID: 31892214 DOI: 10.3390/mi11010036] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Terelius Y, Figler RA, Marukian S, Collado MS, Lawson MJ, Mackey AJ, Manka D, Qualls CW Jr, Blackman BR, Wamhoff BR, Dash A. Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes. Chem Biol Interact 2016;255:31-44. [PMID: 26626330 DOI: 10.1016/j.cbi.2015.11.023] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
27 Le TT, Ziemba A, Urasaki Y, Brotman S, Pizzorno G. Label-free evaluation of hepatic microvesicular steatosis with multimodal coherent anti-Stokes Raman scattering microscopy. PLoS One 2012;7:e51092. [PMID: 23226469 DOI: 10.1371/journal.pone.0051092] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
28 Goyak KM, Johnson MC, Strom SC, Omiecinski CJ. Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures. Toxicol Appl Pharmacol 2008;231:216-24. [PMID: 18559280 DOI: 10.1016/j.taap.2008.04.024] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
29 Guo L, Dial S, Shi L, Branham W, Liu J, Fang JL, Green B, Deng H, Kaput J, Ning B. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab Dispos 2011;39:528-38. [PMID: 21149542 DOI: 10.1124/dmd.110.035873] [Cited by in Crossref: 186] [Cited by in F6Publishing: 179] [Article Influence: 16.9] [Reference Citation Analysis]
30 Yan GZ, Brouwer KL, Pollack GM, Wang MZ, Tidwell RR, Hall JE, Paine MF. Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: comparison of two preclinical hepatic models. J Pharmacol Exp Ther 2011;337:503-12. [PMID: 21320872 DOI: 10.1124/jpet.110.177220] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
31 Yang LQ, Yu WF, Cao YF, Gong B, Chang Q, Yang GS. Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol 2003; 9(9): 1959-1962 [PMID: 12970884 DOI: 10.3748/wjg.v9.i9.1959] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
32 Baxter MA, Rowe C, Alder J, Harrison S, Hanley KP, Park BK, Kitteringham NR, Goldring CE, Hanley NA. Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening. Stem Cell Res 2010;5:4-22. [PMID: 20483202 DOI: 10.1016/j.scr.2010.02.002] [Cited by in Crossref: 48] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
33 Kleinsasser NH, Harréus UA, Gamarra F, Driemel O, Hagen R, Buehrlen M. Cytochrome P4502A6 stability in a mini organ culture model of human nasal mucosa for genotoxicology studies as detected by flow cytometry. Eur Arch Otorhinolaryngol 2009;266:385-9. [PMID: 18648831 DOI: 10.1007/s00405-008-0774-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
34 Tolson AH, Li H, Eddington ND, Wang H. Methadone induces the expression of hepatic drug-metabolizing enzymes through the activation of pregnane X receptor and constitutive androstane receptor. Drug Metab Dispos 2009;37:1887-94. [PMID: 19520773 DOI: 10.1124/dmd.109.027854] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
35 Li L, Stanton JD, Tolson AH, Luo Y, Wang H. Bioactive terpenoids and flavonoids from Ginkgo biloba extract induce the expression of hepatic drug-metabolizing enzymes through pregnane X receptor, constitutive androstane receptor, and aryl hydrocarbon receptor-mediated pathways. Pharm Res 2009;26:872-82. [PMID: 19034627 DOI: 10.1007/s11095-008-9788-8] [Cited by in Crossref: 107] [Cited by in F6Publishing: 102] [Article Influence: 8.2] [Reference Citation Analysis]
36 Okyere J, Oppon E, Dzidzienyo D, Sharma L, Ball G. Cross-species gene expression analysis of species specific differences in the preclinical assessment of pharmaceutical compounds. PLoS One 2014;9:e96853. [PMID: 24823806 DOI: 10.1371/journal.pone.0096853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
37 Soldatow VY, Lecluyse EL, Griffith LG, Rusyn I. In vitro models for liver toxicity testing. Toxicol Res (Camb). 2013;2:23-39. [PMID: 23495363 DOI: 10.1039/c2tx20051a] [Cited by in Crossref: 265] [Cited by in F6Publishing: 112] [Article Influence: 29.4] [Reference Citation Analysis]
38 Jin Y, Yu D, Tolleson WH, Knox B, Wang Y, Chen S, Ren Z, Deng H, Guo Y, Ning B. MicroRNA hsa-miR-25-3p suppresses the expression and drug induction of CYP2B6 in human hepatocytes. Biochem Pharmacol 2016;113:88-96. [PMID: 27311985 DOI: 10.1016/j.bcp.2016.06.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
39 Bell CC, Hendriks DF, Moro SM, Ellis E, Walsh J, Renblom A, Fredriksson Puigvert L, Dankers AC, Jacobs F, Snoeys J, Sison-Young RL, Jenkins RE, Nordling Å, Mkrtchian S, Park BK, Kitteringham NR, Goldring CE, Lauschke VM, Ingelman-Sundberg M. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep 2016;6:25187. [PMID: 27143246 DOI: 10.1038/srep25187] [Cited by in Crossref: 321] [Cited by in F6Publishing: 290] [Article Influence: 64.2] [Reference Citation Analysis]
40 Burton L, Scaife P, Paine SW, Mellor HR, Abernethy L, Littlewood P, Rauch C. Hydrostatic pressure regulates CYP1A2 expression in human hepatocytes via a mechanosensitive aryl hydrocarbon receptor-dependent pathway. Am J Physiol Cell Physiol 2020;318:C889-902. [PMID: 32159360 DOI: 10.1152/ajpcell.00472.2019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Wang YM, Chai SC, Brewer CT, Chen T. Pregnane X receptor and drug-induced liver injury. Expert Opin Drug Metab Toxicol 2014;10:1521-32. [PMID: 25252616 DOI: 10.1517/17425255.2014.963555] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
42 Davidson MD, Ballinger KR, Khetani SR. Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes. Sci Rep 2016;6:28178. [PMID: 27312339 DOI: 10.1038/srep28178] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 8.4] [Reference Citation Analysis]
43 Nishida Y, Taniguchi A. A three-dimensional collagen-sponge-based culture system coated with simplified recombinant fibronectin improves the function of a hepatocyte cell line. In Vitro Cell Dev Biol Anim 2016;52:271-7. [PMID: 26714750 DOI: 10.1007/s11626-015-9973-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
44 Wang Y, Su W, Wang L, Jiang L, Liu Y, Hui L, Qin J. Paper supported long-term 3D liver co-culture model for the assessment of hepatotoxic drugs. Toxicol Res (Camb) 2018;7:13-21. [PMID: 30090558 DOI: 10.1039/c7tx00209b] [Cited by in Crossref: 16] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
45 Štampar M, Breznik B, Filipič M, Žegura B. Characterization of In Vitro 3D Cell Model Developed from Human Hepatocellular Carcinoma (HepG2) Cell Line. Cells 2020;9:E2557. [PMID: 33260628 DOI: 10.3390/cells9122557] [Reference Citation Analysis]
46 Burkhardt B, Martinez-Sanchez JJ, Bachmann A, Ladurner R, Nüssler AK. Long-term culture of primary hepatocytes: new matrices and microfluidic devices. Hepatol Int 2014;8:14-22. [PMID: 26202403 DOI: 10.1007/s12072-013-9487-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
47 Lynch C, Mackowiak B, Huang R, Li L, Heyward S, Sakamuru S, Wang H, Xia M. Identification of Modulators That Activate the Constitutive Androstane Receptor From the Tox21 10K Compound Library. Toxicol Sci 2019;167:282-92. [PMID: 30247703 DOI: 10.1093/toxsci/kfy242] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
48 Nikolic M, Sustersic T, Filipovic N. In vitro Models and On-Chip Systems: Biomaterial Interaction Studies With Tissues Generated Using Lung Epithelial and Liver Metabolic Cell Lines. Front Bioeng Biotechnol 2018;6:120. [PMID: 30234106 DOI: 10.3389/fbioe.2018.00120] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
49 Su S, Di Poto C, Roy R, Liu X, Cui W, Kroemer A, Ressom HW. Long-term culture and characterization of patient-derived primary hepatocytes using conditional reprogramming. Exp Biol Med (Maywood) 2019;244:857-64. [PMID: 31184925 DOI: 10.1177/1535370219855398] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
50 Hedrich WD, Hassan HE, Wang H. Insights into CYP2B6-mediated drug-drug interactions. Acta Pharm Sin B 2016;6:413-25. [PMID: 27709010 DOI: 10.1016/j.apsb.2016.07.016] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 12.4] [Reference Citation Analysis]
51 Olsavsky Goyak KM, Laurenzana EM, Omiecinski CJ. Hepatocyte differentiation. Methods Mol Biol 2010;640:115-38. [PMID: 20645049 DOI: 10.1007/978-1-60761-688-7_6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
52 Williamson B, Lorbeer M, Mitchell MD, Brayman TG, Riley RJ. Evaluation of a novel PXR-knockout in HepaRG cells. Pharmacol Res Perspect 2016;4:e00264. [PMID: 27713827 DOI: 10.1002/prp2.264] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
53 Xuan J, Chen S, Ning B, Tolleson WH, Guo L. Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity. Chem Biol Interact 2016;255:63-73. [PMID: 26477383 DOI: 10.1016/j.cbi.2015.10.009] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 6.3] [Reference Citation Analysis]
54 Bounda GA, Zhou W, Wang DD, Yu F. Rhein Elicits In Vitro Cytotoxicity in Primary Human Liver HL-7702 Cells by Inducing Apoptosis through Mitochondria-Mediated Pathway. Evid Based Complement Alternat Med 2015;2015:329831. [PMID: 26221172 DOI: 10.1155/2015/329831] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
55 Dyavar SR, Mykris TM, Winchester LC, Scarsi KK, Fletcher CV, Podany AT. Hepatocytic transcriptional signatures predict comparative drug interaction potential of rifamycin antibiotics. Sci Rep 2020;10:12565. [PMID: 32724080 DOI: 10.1038/s41598-020-69228-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
56 Strom SC, Davila J, Grompe M. Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol. 2010;640:491-509. [PMID: 20645070 DOI: 10.1007/978-1-60761-688-7_27] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 9.0] [Reference Citation Analysis]
57 Chen Y, Tang Y, Nie JZ, Zhang Y, Nie D. Megestrol acetate is a specific inducer of CYP3A4 mediated by human pregnane X receptor. Cancer Chemother Pharmacol 2021;88:985-96. [PMID: 34524495 DOI: 10.1007/s00280-021-04352-9] [Reference Citation Analysis]
58 Li ZQ, Jiang LL, Zhao DS, Zhou J, Wang LL, Wu ZT, Zheng X, Shi ZQ, Li P, Li HJ. The Modulatory Role of CYP3A4 in Dictamnine-Induced Hepatotoxicity. Front Pharmacol 2018;9:1033. [PMID: 30283337 DOI: 10.3389/fphar.2018.01033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
59 Nassr N, Huennemeyer A, Herzog R, von Richter O, Hermann R, Koch M, Duffy K, Zech K, Lahu G. Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects. Br J Clin Pharmacol 2009;68:580-7. [PMID: 19843061 DOI: 10.1111/j.1365-2125.2009.03478.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
60 Lucendo-Villarin B, Rashidi H, Cameron K, Hay DC. Pluripotent stem cell derived hepatocytes: using materials to define cellular differentiation and tissue engineering. J Mater Chem B 2016;4:3433-42. [PMID: 27746914 DOI: 10.1039/c6tb00331a] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
61 Lee SY, Kim HJ, Choi D. Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation. Int J Stem Cells. 2015;8:36-47. [PMID: 26019753 DOI: 10.15283/ijsc.2015.8.1.36] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 7.8] [Reference Citation Analysis]
62 Ploss A, Khetani SR, Jones CT, Syder AJ, Trehan K, Gaysinskaya VA, Mu K, Ritola K, Rice CM, Bhatia SN. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A 2010;107:3141-5. [PMID: 20133632 DOI: 10.1073/pnas.0915130107] [Cited by in Crossref: 164] [Cited by in F6Publishing: 147] [Article Influence: 14.9] [Reference Citation Analysis]
63 Satoh D, Iwado S, Abe S, Kazuki K, Wakuri S, Oshimura M, Kazuki Y. Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies. PLoS One 2017;12:e0187072. [PMID: 29065189 DOI: 10.1371/journal.pone.0187072] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
64 Bhatia SN, Underhill GH, Zaret KS, Fox IJ. Cell and tissue engineering for liver disease. Sci Transl Med. 2014;6:245sr2. [PMID: 25031271 DOI: 10.1126/scitranslmed.3005975] [Cited by in Crossref: 178] [Cited by in F6Publishing: 165] [Article Influence: 29.7] [Reference Citation Analysis]
65 Wright KM, Magana AA, Laethem RM, Moseley CL, Banks TT, Maier CS, Stevens JF, Quinn JF, Soumyanath A. Centella asiatica Water Extract Shows Low Potential for Cytochrome P450-Mediated Drug Interactions. Drug Metab Dispos 2020;48:1053-63. [PMID: 32581050 DOI: 10.1124/dmd.120.090860] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
66 Bulutoglu B, Rey-Bedón C, Mert S, Tian L, Jang YY, Yarmush ML, Usta OB. A comparison of hepato-cellular in vitro platforms to study CYP3A4 induction. PLoS One 2020;15:e0229106. [PMID: 32106230 DOI: 10.1371/journal.pone.0229106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
67 Maher SP, Crouse RB, Conway AJ, Bannister EC, Achyuta AK, Clark AY, Sinatra FL, Cuiffi JD, Adams JH, Kyle DE, Saadi WM. Microphysical space of a liver sinusoid device enables simplified long-term maintenance of chimeric mouse-expanded human hepatocytes. Biomed Microdevices 2014;16:727-36. [PMID: 24907052 DOI: 10.1007/s10544-014-9877-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
68 LeCluyse EL, Witek RP, Andersen ME, Powers MJ. Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol. 2012;42:501-548. [PMID: 22582993 DOI: 10.3109/10408444.2012.682115] [Cited by in Crossref: 226] [Cited by in F6Publishing: 200] [Article Influence: 25.1] [Reference Citation Analysis]
69 Tascher G, Burban A, Camus S, Plumel M, Chanon S, Le Guevel R, Shevchenko V, Van Dorsselaer A, Lefai E, Guguen-Guillouzo C, Bertile F. In-Depth Proteome Analysis Highlights HepaRG Cells as a Versatile Cell System Surrogate for Primary Human Hepatocytes. Cells 2019;8:E192. [PMID: 30795634 DOI: 10.3390/cells8020192] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
70 Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, McLeod HL. Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. Clin Pharmacokinet. 2005;44:279-304. [PMID: 15762770 DOI: 10.2165/00003088-200544030-00005] [Cited by in Crossref: 315] [Cited by in F6Publishing: 279] [Article Influence: 19.7] [Reference Citation Analysis]
71 Heath RD, Ertem F, Romana BS, Ibdah JA, Tahan V. Hepatocyte transplantation: Consider infusion before incision. World J Transplant 2017; 7(6): 317-323 [PMID: 29312860 DOI: 10.5500/wjt.v7.i6.317] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Su S, Di Poto C, Kroemer AH, Cui W, Roy R, Liu X, Ressom HW. Establishment of ornithine transcarbamylase deficiency-derived primary human hepatocyte with hepatic functions. Exp Cell Res 2019;384:111621. [PMID: 31513782 DOI: 10.1016/j.yexcr.2019.111621] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
73 Yu Y, Wang X, Nyberg SL. Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment. J Clin Med 2014;3:997-1017. [PMID: 26237490 DOI: 10.3390/jcm3030997] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
74 Ramachandran SD, Vivarès A, Klieber S, Hewitt NJ, Muenst B, Heinz S, Walles H, Braspenning J. Applicability of second-generation upcyte® human hepatocytes for use in CYP inhibition and induction studies. Pharmacol Res Perspect 2015;3:e00161. [PMID: 26516577 DOI: 10.1002/prp2.161] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
75 Li L, Hassan HE, Tolson AH, Ferguson SS, Eddington ND, Wang H. Differential activation of pregnane X receptor and constitutive androstane receptor by buprenorphine in primary human hepatocytes and HepG2 cells. J Pharmacol Exp Ther 2010;335:562-71. [PMID: 20829393 DOI: 10.1124/jpet.110.173187] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
76 Moeller TA, Shukla SJ, Xia M. Assessment of compound hepatotoxicity using human plateable cryopreserved hepatocytes in a 1536-well-plate format. Assay Drug Dev Technol 2012;10:78-87. [PMID: 22053711 DOI: 10.1089/adt.2010.0365] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
77 Caccia S, Garattini S, Pasina L, Nobili A. Predicting the clinical relevance of drug interactions from pre-approval studies. Drug Saf 2009;32:1017-39. [PMID: 19810775 DOI: 10.2165/11316630-000000000-00000] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
78 Guzmán-Delgado NE, Carranza-Torres IE, García-Davis S, Rivera G, Morán-Martínez J, Betancourt-Martínez ND, Groothuis GMM, de Graaf IAM, Carranza-Rosales P. Development of a Novel Ex-vivo 3D Model to Screen Amoebicidal Activity on Infected Tissue. Sci Rep 2019;9:8396. [PMID: 31182753 DOI: 10.1038/s41598-019-44899-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Theobald J, Abu El Maaty MA, Kusterer N, Wetterauer B, Wink M, Cheng X, Wölfl S. In vitro metabolic activation of vitamin D3 by using a multi-compartment microfluidic liver-kidney organ on chip platform. Sci Rep 2019;9:4616. [PMID: 30874583 DOI: 10.1038/s41598-019-40851-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
80 Swift B, Pfeifer ND, Brouwer KL. Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity. Drug Metab Rev 2010;42:446-71. [PMID: 20109035 DOI: 10.3109/03602530903491881] [Cited by in Crossref: 262] [Cited by in F6Publishing: 233] [Article Influence: 23.8] [Reference Citation Analysis]
81 Yoshioka M, Takenouchi T, Kitani H, Guruge KS, Yamanaka N. Synergistic induction of drug-metabolizing enzymes in co-cultures of bovine hepatocytic and sinusoidal cell lines. In Vitro Cell Dev Biol Anim 2020;56:2-9. [PMID: 31722089 DOI: 10.1007/s11626-019-00408-6] [Reference Citation Analysis]
82 Kia R, Sison RL, Heslop J, Kitteringham NR, Hanley N, Mills JS, Park BK, Goldring CE. Stem cell-derived hepatocytes as a predictive model for drug-induced liver injury: are we there yet? Br J Clin Pharmacol. 2013;75:885-896. [PMID: 22703588 DOI: 10.1111/j.1365-2125.2012.04360.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
83 Svejda B, Kidd M, Timberlake A, Harry K, Kazberouk A, Schimmack S, Lawrence B, Pfragner R, Modlin IM. Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors. Cancer Sci 2013;104:844-55. [PMID: 23578138 DOI: 10.1111/cas.12174] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
84 Wang D, Li L, Fuhrman J, Ferguson S, Wang H. The role of constitutive androstane receptor in oxazaphosphorine-mediated induction of drug-metabolizing enzymes in human hepatocytes. Pharm Res 2011;28:2034-44. [PMID: 21487929 DOI: 10.1007/s11095-011-0429-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
85 Mandon M, Huet S, Dubreil E, Fessard V, Le Hégarat L. Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay. Sci Rep 2019;9:10548. [PMID: 31332230 DOI: 10.1038/s41598-019-47114-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 13.5] [Reference Citation Analysis]
86 Proctor WR, Foster AJ, Vogt J, Summers C, Middleton B, Pilling MA, Shienson D, Kijanska M, Ströbel S, Kelm JM, Morgan P, Messner S, Williams D. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury. Arch Toxicol 2017;91:2849-63. [PMID: 28612260 DOI: 10.1007/s00204-017-2002-1] [Cited by in Crossref: 131] [Cited by in F6Publishing: 111] [Article Influence: 32.8] [Reference Citation Analysis]
87 Dash A, Inman W, Hoffmaster K, Sevidal S, Kelly J, Obach RS, Griffith LG, Tannenbaum SR. Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol 2009;5:1159-74. [PMID: 19637986 DOI: 10.1517/17425250903160664] [Cited by in Crossref: 117] [Cited by in F6Publishing: 110] [Article Influence: 9.8] [Reference Citation Analysis]
88 Bale SS, Vernetti L, Senutovitch N, Jindal R, Hegde M, Gough A, McCarty WJ, Bakan A, Bhushan A, Shun TY, Golberg I, DeBiasio R, Usta BO, Taylor DL, Yarmush ML. In vitro platforms for evaluating liver toxicity. Exp Biol Med (Maywood) 2014;239:1180-91. [PMID: 24764241 DOI: 10.1177/1535370214531872] [Cited by in Crossref: 107] [Cited by in F6Publishing: 97] [Article Influence: 15.3] [Reference Citation Analysis]
89 Emzhik M, Rahimi-Moghaddam P, Ebrahimi SA, Keyhanfar F, Moazzam AS. Commentary on prevention a possible drug-drug interaction: is concurrent administration of orlistat and pioglitazone increase the risk of durg-induced hepatotoxicity? Int J Prev Med 2015;6:16. [PMID: 25789148 DOI: 10.4103/2008-7802.151825] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]